We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
-16.56%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$35.3B
AUM Growth
-$2.37B
(-6.3%)
Cap. Flow
+$5.08B
Cap. Flow
% of AUM
14.42%
Top 10 Holdings %
Top 10 Hldgs %
12.79%
Holding
3,021
New
306
Increased
1,176
Reduced
1,104
Closed
398
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$410M |
| 2 |
Snap
SNAP
|
+$321M |
| 3 |
Altria Group
MO
|
+$312M |
| 4 |
Meta Platforms (Facebook)
META
|
+$295M |
| 5 |
Intel
INTC
|
+$283M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CERN
Cerner Corp
CERN
|
+$407M |
| 2 |
AbbVie
ABBV
|
+$283M |
| 3 |
S&P Global
SPGI
|
+$251M |
| 4 |
Amazon
AMZN
|
+$221M |
| 5 |
Eli Lilly
LLY
|
+$197M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.06% |
| 2 | Healthcare | 18.6% |
| 3 | Financials | 10.47% |
| 4 | Industrials | 10.2% |
| 5 | Consumer Discretionary | 7.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2326
Tarsus Pharmaceuticals
TARS
$2.62B
| $155K | ﹤0.01% |
+10,600
| New | +$159K |
|
2327
Tredegar Corp
TG
$260M
| $155K | ﹤0.01% |
15,500
-3,700
| -19% | -$42.9K |
|
|
TVRD
2328
Tvardi Therapeutics
TVRD
$23.8M
| $155K | ﹤0.01% |
472
-20
| -4% | -$7.02K |
|
|
CWBR
2329
DELISTED
CohBar, Inc. Common Stock
CWBR
| $155K | ﹤0.01% |
27,173
-10,860
| -29% | -$72.6K |
|
2330
Custom Truck One Source
CTOS
$2.44B
| $153K | ﹤0.01% |
27,400
-20,400
| -43% | -$130K |
|
2331
Orion Group Holdings
ORN
$503M
| $153K | ﹤0.01% |
67,300
+18,800
| +39% | +$48.4K |
|
2332
Rush Street Interactive
RSI
$3.26B
| $153K | ﹤0.01% |
32,700
-63,500
| -66% | -$378K |
|
|
CMCT
2333
Creative Media & Community Trust
CMCT
$8.28M
| $151K | ﹤0.01% |
1
-1
| -50% | -$177K |
|
|
KLRS
2334
Kalaris Therapeutics
KLRS
$85.2M
| $151K | ﹤0.01% |
1,678
+430
| +34% | +$45.1K |
|
|
ONCT
2335
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
| $150K | ﹤0.01% |
6,755
+1,980
| +41% | +$44.1K |
|
2336
BBVA Argentina
BBAR
$3.92B
| $149K | ﹤0.01% |
62,300
+33,600
| +117% | +$99.7K |
|
2337
Perella Weinberg Partners
PWP
$1.18B
| $149K | ﹤0.01% |
25,600
+5,200
| +25% | +$37.6K |
|
|
SCU
2338
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
| $149K | ﹤0.01% |
17,900
-9,800
| -35% | -$108K |
|
|
VCSA
2339
DELISTED
Vacasa, Inc. Class A Common Stock
VCSA
| $149K | ﹤0.01% |
+2,595
| New | +$274K |
|
|
LUNA
2340
DELISTED
Luna Innovations Incorporated
LUNA
| $149K | ﹤0.01% |
+25,600
| New | +$151K |
|
2341
QuinStreet
QNST
$893M
| $148K | ﹤0.01% |
14,700
+3,800
| +35% | +$40K |
|
|
WE
2342
DELISTED
WeWork Inc.
WE
| $148K | ﹤0.01% |
+738
| New | +$190K |
|
|
VVNT
2343
DELISTED
Vivint Smart Home, Inc. Class A Common Stock
VVNT
| $144K | ﹤0.01% |
41,400
+15,500
| +60% | +$82.6K |
|
|
FLNT
2344
Fluent
FLNT
$99.9M
| $141K | ﹤0.01% |
19,800
+6,883
| +53% | +$57.4K |
|
|
NVNO
2345
enVVeno Medical
NVNO
$7.12M
| $140K | ﹤0.01% |
1,057
-360
| -25% | -$55.9K |
|
2346
Atossa Therapeutics
ATOS
$23.5M
| $139K | ﹤0.01% |
8,487
-36,953
| -81% | -$582K |
|
2347
Anavex Life Sciences
AVXL
$232M
| $139K | ﹤0.01% |
13,900
-17,100
| -55% | -$162K |
|
2348
Genius Sports
GENI
$1.94B
| $139K | ﹤0.01% |
61,900
-83,000
| -57% | -$280K |
|
2349
Solid Biosciences
SLDB
$777M
| $139K | ﹤0.01% |
15,107
-9,760
| -39% | -$101K |
|
2350
Xponential Fitness
XPOF
$278M
| $138K | ﹤0.01% |
11,000
-42,300
| -79% | -$762K |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q2 2022 Portfolio in Review
As of Q2 2022, Two Sigma Advisers held 3,021 positions worth $35.3B, down 6.3% from $37.6B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Two Sigma Advisers deployed $5.08B of net new capital in Q2 2022, opening 306 new positions and adding to 1,176 existing holdings. Its largest new stake was Snap: 14,064,077 shares worth $185M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was AbbVie, an estimated $283M trimmed.
- Two Sigma Advisers's largest Q2 2022 buy was Snap: 14,064,077 shares worth $185M.
- Two Sigma Advisers added most to Netflix in Q2 2022, an estimated $410M increase.
- Two Sigma Advisers's biggest Q2 2022 reduction was AbbVie, cutting an estimated $283M.
- Two Sigma Advisers fully exited Cerner Corp in Q2 2022, selling an estimated $407M.
- Two Sigma Advisers's ten largest holdings make up 13% of its $35.3B portfolio in Q2 2022.
- Two Sigma Advisers opened 306 new positions and closed 398 in Q2 2022.
- Two Sigma Advisers's portfolio value fell 6.3% quarter-over-quarter to $35.3B.
Based on Two Sigma Advisers's 13F filing for Q2 2022, filed 15 Aug 2022.